Good Sunday morning!

It’s Christin, your bioeconomy enthusiast, and it’s time for some bioeconomy reading! Here’s a quick roundup of the stories, developments, and discussions that shaped the field this week.

Over the past decade and a half, the objectives of bioeconomy policy have undergone a remarkable shift. In the Global Bioeconomy Policy Reports (I–IV), we analyzed these developments, which have shifted from an initial focus on innovation and economic growth to a broader agenda centered on sustainability, decarbonization, and circular economy approaches. The COVID-19 pandemic marked a turning point. It revealed how dependent modern societies are on resilient supply chains. Consequently, the bioeconomy has began to be framed not only as a sustainability strategy, but also as a key pillar of resilience and crisis preparedness. In recent years, yet another shift has become apparent. Many countries now emphasize competitiveness, industrial scale-up, and the strategic security of supply. The bioeconomy is increasingly seen as an instrument of industrial policy and a driver of technological leadership.

However, the article “The bioeconomy in a world at war” suggests that this is not the end of the story. In a world shaped by geopolitical tensions and economic fragmentation, the bioeconomy is playing an even broader role, linking sustainability, resilience, and competitiveness in the pursuit of stable and future-proof economic systems.

🇨🇳 What do Chinese Biotech Subsidies Cover? (Bio Brawl on Substack)

🇨🇳 Pathway mechanisms, policy frameworks, and comprehensive impacts of biomanufacturing in industrial transformation and upgrading (Asia Pacific Science Press)

🇪🇺 Beyond Competitiveness: Futures of EU’s competitiveness and sustainability and the importance of bioeconomy, industrial transformation, and critical raw materials (European Environment Agency)

🇦🇺 & 🇮🇳 Broad overview on the biomanufacturing ecosystems in India and Australia (BiaSPARK)

🇮🇳 Tamil Nadu releases BioVision 2026 (ABLE India)

🇮🇳 Indian Institute of Management Sambalpur invites public comments on the draft framework for Odisha’s first Bioeconomy Policy (Invitation of Public Comments)

🇮🇳 Draft Kerala Biotechnology Policy 2026, aiming to transform the State into a global bioeconomy hub (Government of Kerala)

🇵🇦 Leaders from 12 Latin American countries discuss how to consolidate and deepen regional advances in bioeconomy (IICA)

🇺🇸 The U.S. celebrated the fourth National Biobased Products Day on March, 8 (USDA)

🇺🇸 Defense Advanced Research Projects Agency (DARPA) is funding bio-based technologies to strengthen U.S. supply chains for critical minerals, including programs such as EMBER (engineering microbes to extract rare earth elements from domestic ores), SMASH (bio-based separation of elements across the periodic table), and Fleetwood (converting agricultural waste into industrial chemicals), alongside scale-up support from BioMADE to build a domestic bioindustrial infrastructure addressing heavy U.S. reliance on imported minerals. (Balaji Vasudevan via LinkedIn)

Not a development from this week, but still widely discussed across policy and industry circles: on 4 March the proposal for the Industrial Acceleration Act (IAA) was published. Reactions in the bioeconomy community, particularly on LinkedIn, were mixed. Some observers pointed out that the pharmaceutical industry and the bioeconomy are not included. Others noted that the draft regulation explicitly recognizes the bioeconomy’s potential to “provide sustainable biomass and bio-based solutions for industrial production.”

However, a closer look reveals that the reference to the bioeconomy is not included in the binding legal provisions but rather in the Explanatory Memorandum, which is the political justification that accompanies the proposal. Here, the Commission states that “the bioeconomy is able to provide sustainable biomass and bio-based solutions for industrial production.” The text also refers to the EU Bioeconomy Strategy, published in 2025, which identified lead markets, such as bio-based plastics and polymers, bio-based chemicals and bio-based construction products, as well as lead technologies that support strategic autonomy and industrial decarbonization.

Legally, this passage is not operational, as it does not create obligations or measures. Politically, however, it is significant. It frames the bioeconomy as an enabler of industrial decarbonization: a source of sustainable biomass that can support bio-based materials and industrial solutions.

The proposal’s message can be interpreted in three ways:

This raises an open question for the legislative process ahead: If bio-based solutions are strategically relevant for decarbonization, should they be reflected more explicitly in the regulation itself?

The proposal is only the beginning of what will likely be a long legislative process, with negotiations, amendments and implementation rules still to come. For now, the signal is clear: the bioeconomy is entering the language of EU industrial policy, but its exact role is still being negotiated.

That’s it for this week’s Bioeconomy Policy Brief.

If you found this useful, share it with colleagues working on bioeconomy policy.

Have a wonderful week ahead!